Patents by Inventor Aaron David WROBLESKI

Aaron David WROBLESKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MET antibody drug conjugates
    Patent number: 11167039
    Abstract: Provided are antibody-drug conjugates (ADCs) that bind to, and kill MET expressing tumor cells, and that are effective in treating MET expressing cancers. Also provided are novel compounds and methods of conjugating MET antibodies to generate such ADCs.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: November 9, 2021
    Assignee: Eli Lilly and Company
    Inventors: Yiqing Feng, Philip Arthur Hipskind, Renhua Li, Ling Liu, Takako Wilson, Aaron David Wrobleski
  • MET ANTIBODY DRUG CONJUGATES
    Publication number: 20200061204
    Abstract: Provided are antibody-drug conjugates (ADCs) that bind to, and kill MET expressing tumor cells, and that are effective in treating MET expressing cancers. Also provided are novel compounds and methods of conjugating MET antibodies to generate such ADCs.
    Type: Application
    Filed: November 17, 2017
    Publication date: February 27, 2020
    Inventors: Yiqing FENG, Philip Arthur HIPSKIND, Renhua LI, Ling LIU, Takako WILSON, Aaron David WROBLESKI